The nation of Zimbabwe has turned down a major American healthcare agreement valued at $367m (£272m) spanning five years over Washington's demand for confidential information.
This move became public following a government memo from December was disclosed, which showed President Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesman later explained that the US was requesting health data for scientific study and commercial gain while was unwilling to guarantee the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for continued talks to secure a agreement suitable to both sides so the nation's critical HIV programme can continue.
Broader Context
This rejection comes after a similar case in neighbouring Kenya, where a court suspended a similar health funding agreement after legal challenges were raised about the safety of citizens' health data.
Since returning to office recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.
Based on reports, Sixteen nations in Africa have so far agreed to similar health pacts, representing over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our citizens if a new disease outbreak arise."
National Interest and Global Health
Mangwana further noted that the American exit from the global health body and its push of bilateral health agreements were upending frameworks already set up through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This mechanism is intended to guarantee that when a country provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."
The government's concerns over the US deal "should not be misconstrued as opposition to America," he added.
"We are open to continued dialogue with our US partners on how future collaboration could be designed in a way that respects the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that negotiations should continue given that a large portion of the nation's Aids initiatives were funded by international support.
"If technical issues arise, including those involving information security or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group said.
The halted deal emphasises the ongoing tensions between receiving vital international aid and safeguarding local interests in an ever more data-driven world.